We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$106B
AUM Growth
+$2.27B
Cap. Flow
-$488M
Cap. Flow %
-0.46%
Top 10 Hldgs %
30.07%
Holding
4,478
New
179
Increased
2,056
Reduced
1,848
Closed
61

Top Buys

Rank Stock Value
1
XOM icon
ExxonMobil
XOM
+$101M
2
GEV icon
GE Vernova
GEV
+$75.4M
3
CRH icon
CRH
CRH
+$48.5M
4
CRWD icon
CrowdStrike
CRWD
+$45.8M
5
DELL icon
Dell
DELL
+$35.8M

Sector Composition

Rank Sector Weight
1 Technology 30.98%
2 Financials 12.55%
3 Healthcare 11.48%
4 Consumer Discretionary 10.52%
5 Industrials 8.86%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BP icon
2176
BP
BP
$107B
$1.06M ﹤0.01%
29,235
+571
+2% +$21.4K
EVRI
2177
DELISTED
Everi Holdings
EVRI
$1.05M ﹤0.01%
125,137
+4,486
+4% +$36.6K
BF
2178
DELISTED
BASF AKTIENGESELLT ADS(RP1 ORD
BF
$1.05M ﹤0.01%
86,882
+2,087
+2% +$25.2K
AMCX icon
2179
AMC Global Media
AMCX
$489M
$1.05M ﹤0.01%
108,636
+592
+0.5% +$7.81K
KNSA icon
2180
Kiniksa Pharmaceuticals
KNSA
$5.93B
$1.05M ﹤0.01%
56,066
-5,365
-9% -$101K
DT
2181
DELISTED
DEUTSCHE TELEKOM AG ADS (1ORD)
DT
$1.04M ﹤0.01%
41,332
+5,143
+14% +$130K
CFB
2182
DELISTED
CrossFirst Bankshares, Inc. Common Stock
CFB
$1.04M ﹤0.01%
74,214
+1,895
+3% +$24.5K
PLRX icon
2183
Pliant Therapeutics
PLRX
$65M
$1.04M ﹤0.01%
96,488
+14,662
+18% +$189K
IAS
2184
DELISTED
Integral Ad Science
IAS
$1.04M ﹤0.01%
106,697
+31,145
+41% +$298K
TVTX icon
2185
Travere Therapeutics
TVTX
$5.78B
$1.03M ﹤0.01%
125,660
+18,645
+17% +$126K
ETNB
2186
DELISTED
89bio
ETNB
$1.03M ﹤0.01%
128,944
+27,334
+27% +$244K
TRI icon
2187
Thomson Reuters
TRI
$44.1B
$1.03M ﹤0.01%
6,015
-139
-2% -$23K
MBWM icon
2188
Mercantile Bank Corp
MBWM
$1.05B
$1.03M ﹤0.01%
25,321
+655
+3% +$24.5K
PNTG icon
2189
Pennant Group
PNTG
$1.36B
$1.03M ﹤0.01%
44,239
+3,611
+9% +$79.1K
BUD icon
2190
AB InBev
BUD
$165B
$1.03M ﹤0.01%
17,632
+944
+6% +$57.8K
EU
2191
enCore Energy
EU
$243M
$1.03M ﹤0.01%
260,172
+17,191
+7% +$76K
BHP icon
2192
BHP
BHP
$230B
$1.02M ﹤0.01%
17,942
-2,147
-11% -$125K
IMAX icon
2193
IMAX
IMAX
$2.66B
$1.02M ﹤0.01%
61,060
-2,446
-4% -$40.5K
NAB
2194
DELISTED
NATL AUSTRALIA BK LTD ADS5
NAB
$1.02M ﹤0.01%
84,652
+9,156
+12% +$110K
NMRA icon
2195
Neumora Therapeutics
NMRA
$302M
$1.02M ﹤0.01%
103,258
+85,706
+488% +$887K
BVN icon
2196
Compañía de Minas Buenaventura
BVN
$8.67B
$1.01M ﹤0.01%
59,819
+3,877
+7% +$65.5K
TK icon
2197
Teekay
TK
$985M
$1.01M ﹤0.01%
112,957
-3,003
-3% -$25.3K
VTS icon
2198
Vitesse Energy
VTS
$665M
$1.01M ﹤0.01%
42,572
+1,257
+3% +$29.9K
ALAB icon
2199
Astera Labs
ALAB
$58B
$1.01M ﹤0.01%
+16,673
New +$1.16M
VVX icon
2200
V2X
VVX
$2.65B
$1.01M ﹤0.01%
20,991
+863
+4% +$40.9K

Similar funds

RhumbLine Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, RhumbLine Advisers held 4,478 positions worth $106B, up 2.2% from $104B the previous quarter. Its ten largest holdings account for 30% of the portfolio.

RhumbLine Advisers's Q2 2024 filing shows 179 new, 2,056 increased, 1,848 reduced and 61 closed positions. Its largest new stake was GE Vernova: 475,685 shares worth $81.6M. The largest sale was iShares Russell 1000 ETF, an estimated $180M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q2 2024 buy was GE Vernova: 475,685 shares worth $81.6M.
  • RhumbLine Advisers added most to ExxonMobil in Q2 2024, an estimated $101M increase.
  • RhumbLine Advisers's biggest Q2 2024 reduction was iShares Russell 1000 ETF, cutting an estimated $180M.
  • RhumbLine Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $121M.
  • RhumbLine Advisers's ten largest holdings make up 30% of its $106B portfolio in Q2 2024.
  • RhumbLine Advisers opened 179 new positions and closed 61 in Q2 2024.
  • RhumbLine Advisers's portfolio value rose 2.2% quarter-over-quarter to $106B.

Based on RhumbLine Advisers's 13F filing for Q2 2024, filed 1 Aug 2024.